CD8A and neoplasm: In mesothelioma AB12 tumors of SM16-treated mice, in vivo depletion of CD8+ T cells by mAb injection canceled the reduction in tumor growth, indicating a dependence of TAN anti-tumor effects on CD8+ T cells.